The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: An evidence-based review

This publication has 167 references indexed in Scilit:

• Myeloablative Treatments for Multiple Myeloma: Update of a Comparative Study of Different Regimens Used in Patients from the Spanish Registry for Transplantation in Multiple Myeloma
  Leukemia & Lymphoma, 2002
• Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma
  Bone Marrow Transplantation, 2001
• Syngeneic transplantation in multiple myeloma – a case-matched comparison with autologous and allogeneic transplantation
  Bone Marrow Transplantation, 1999
• Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma
  Bone Marrow Transplantation, 1998
• Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma
  Bone Marrow Transplantation, 1998
• High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency
  Bone Marrow Transplantation, 1997
• Autologous and allogeneic transplantation for multiple myeloma at a single centre
  Bone Marrow Transplantation, 1997
• Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests
  British Journal of Haematology, 1996
• The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma
  European Journal Of Cancer, 1994
• Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to the ebmt registry
  Hematological Oncology, 1988